Inventor · disambiguated record
J. Merritt
Also filed as: MERRITT J R · MERRITT J ROBERT
9 granted patents·8 pending applications·137 citations·filing 2002–2011
88Inventor score
Top patents by PatentIndex Score
17 records- 0194US7132445B23,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Nov 7, 2006·58 cites·82 claims
- 0288US7964646B23,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2006·Granted Jun 21, 2011·10 cites·47 claims
- 0388US7947720B23,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2009·Granted May 24, 2011·10 cites·4 claims
- 0485US6903131B23,4-di-substituted maleimide compounds as CXC chemokine receptor antagonistsPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted Jun 7, 2005·28 cites·21 claims
- 0584US6878709B23,4-di-substituted pyridazinediones as CXC chemokine receptor antagonistsSCHERING CORP·Filed 2003·Granted Apr 12, 2005·20 cites·4 claims
- 0678US7691856B2Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligandsSCHERING CORP·Filed 2007·Granted Apr 6, 2010·3 cites·67 claims
- 0770US7338968B2Thiadiazoles AS CXC- and CC- chemokine receptor ligandsSCHERING CORP·Filed 2004·Granted Mar 4, 2008·4 cites·46 claims
- 0869US7671212B2Isothiazole dioxides as CXC- and CC-chemokine receptor ligandsSCHERING CORP·Filed 2004·Granted Mar 2, 2010·4 cites·39 claims
- 0956US7786149B2Thiadiazoles as CXC- and CC- chemokine receptor ligandsSCHERING CORP·Filed 2007·Granted Aug 31, 2010·0 cites·19 claims
- 1053US2011213029A13,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor LigandsSCHERING CORP·Filed 2011·Application pending·0 cites
- 1152US2004106794A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2002·Application pending·0 cites
- 1249US2004186142A1Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligandsSCHERING CORP PHARMACOPEIA INC·Filed 2003·Application pending·0 cites
- 1346US2004235908A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonistsSCHERING CORP·Filed 2004·Application pending·0 cites
- 1444US2003204085A13, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonistsFiled 2002·Application pending·0 cites
- 1543US2008045489A13,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligandsCHAO JIANHUA·Filed 2007·Application pending·0 cites
- 1639US2003097004A13,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonistsSCHERING CORP·Filed 2002·Application pending·0 cites
- 1735US2004097547A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →